Michelle F Davis / Bloomberg:
Benchling, which makes cloud-based software to manage biotech R&D, raises a $100M Series F at a $6.1B valuation; Benchling was last valued at $4B in April — – New investor Franklin Templeton leads round with Altimeter — Companies using firm’s software include Regeneron, Eli Lilly
Sophia
Sophia is an entrepreneur and blogger. She is passionate about software, disruptive technology, personal development, and inspiring others.
Add A Comment